CNCNYSEHospital & Medical Service PlansFiscal year ends December 31
CENTENE CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026
$68.63−0.53 (-0.77%)
Close on Oct 19, 2026
- Market cap
- $34.15B
- P/E (TTM)
- –
- Dividend yield
- –
CENTENE CORP revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other | $1.20B | $1.18B | $1.28B | $1.34B | $1.22B | $1.28B | $1.27B | $1.25B | $1.21B | $1.19B | $1.53B | $1.47B | 2.2% | -2.3% |
| Commercial | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | 0.0% | – |
| Medicaid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | 0.0% | – |
| Medicare | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | 0.0% | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Premium and service revenues | $44.38B | $44.66B | $44.73B | $44.90B | $42.47B | $42.49B | $36.30B | $36.90B | $35.97B | $36.34B | $35.34B | $34.97B | 82.8% | +4.5% |
| Premium | $43.58B | $43.89B | $43.98B | $44.13B | $41.74B | $41.71B | $35.52B | $36.12B | $35.14B | $35.53B | $34.23B | $33.87B | 81.3% | +4.4% |
| Service | $793.00M | $768.00M | $749.00M | $772.00M | $727.00M | $777.00M | $777.00M | $784.00M | $833.00M | $808.00M | $1.11B | $1.10B | 1.5% | +9.1% |
By region
From the segment and revenue-disaggregation notes of Centene's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.